Important note
This AI stock analysis for Aehr Test Systems is not up to date. Creating and accessing our AI stock Analysis (powered by our data and Chat GPT) is only available for our premium users. Sign up to get access today!
Aehr Test Systems - AI Stock Analysis
Analysis generated May 30, 2025
Aehr Test Systems is a company that designs, engineers, and manufactures test and burn-in equipment used in the semiconductor industry. The firm is known for its innovative solutions that address key issues such as yield learning and failure analytic capabilities, both of which are crucial for semiconductor manufacturers. Aehr Test Systems has carved out its niche by focusing on dynamic and increasing demands in the semiconductor sector, making it a potentially strong investment candidate.
Fundamental Analysis
Aehr Test Systems has demonstrated significant growth in its financial metrics, showing resilience and adaptability in a competitive sector. The revenue for the last quarter was $18M, marking a sizeable increase of 36.08% compared to the previous quarter and a robust 142.06% increase year-over-year. These figures highlight a strong period of revenue growth, suggesting that the company's services and products are in increasing demand.
The Net income for the last quarter was $640,000, a leap of 37.45% from the preceding quarter and an impressive 56.29% higher than the same quarter last year. This positive turn in net income showcases improved profitability, which is a good sign for investors.
EBITDA for the last quarter was $1.1M, up by 26.04% from the previous quarter and a rise of 33.19% year-over-year. This uptick in EBITDA reinforces the company's operational efficiency and profitability potential.
The current P/E ratio stands at 12.9, which is within the normal range, suggesting that the stock is reasonably priced relative to its earnings.
Technical Analysis
The current stock price of Aehr Test Systems is $9.45, reflecting an increase of 10.79% from a month ago, which indicates a positive short-term trend. However, the stock has decreased by 17.90% over the last year, signaling potential long-term concerns.
The trend is bullish. The current SMA10 is 9.21, higher than the previous SMA10 of 9.16, indicating a potential upward movement in the stock price. The RSI is 69.3, which is neutral, suggesting the stock is neither overbought nor oversold.
Alternative Data Analysis
Aehr Test Systems has 2 job openings, a number that has been stable, indicating that the company is currently not in a significant expansion or contraction phase. Employee sentiment is exceptionally high, with 100% of employees expressing a positive business outlook, a strong positive indicator.
However, customer acquisition metrics show an estimated 4,000 visitors to their webpage, a decrease of 75% in recent months. This drop in page visits could indicate a potential loss in customer interest or engagement. Nevertheless, according to AltIndex's AI score, which aggregates fundamental, technical, and alternative data analysis, Aehr Test Systems has a score of 63, signaling a buy recommendation.
Conclusion and Recommendation
In summary, Aehr Test Systems displays a strong financial performance with significant growth in revenue, net income, and EBITDA, suggesting robust operational efficiency and profitability. The stock is currently showing a positive short-term trend, although long-term trends indicate caution. Alternative data presents a mixed picture; while employee sentiment is high, a drop in website visitors is concerning. Despite these mixed signals, the AI score is a buy, suggesting that potential gains may outweigh the risks in the near term.
Based on the analysis, one could consider Aehr Test Systems a promising investment option, especially for those looking for short to medium-term gains. However, it would be prudent to closely monitor any further declines in customer acquisition metrics and long-term price movements as part of ongoing due diligence.
Disclaimer: This AI stock analysis, generated by an experimental AI tool, is for informational purposes only and not financial advice. Information is based on publicly available data and may not always be accurate or current.